Literature DB >> 8940398

Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation.

A C Hägglund1, A Ny, K Liu, T Ny.   

Abstract

Several lines of indirect evidence indicate that plasmin-mediated proteolysis plays a role in the breakdown of the follicle wall during ovulation. Consistent with this, the ovulation efficiency of mice lacking the two known physiological plasminogen activators (PAs), tissue-type PA (tPA) and urokinase-type PA (uPA), is reduced by 26%. Surprisingly, mice with a single deficiency of either tPA or uPA gene function were normal in their capacity to ovulate. In this study we used in situ hybridization and casein in situ zymography to localize the expression of messenger RNAs (mRNAs) encoding PAs and PA inhibitors and to examine the net PA activity in the mouse ovary at the time of ovulation. Although uPA mRNA expressed by granulosa cells is the most abundant and dramatically up-regulated PA before ovulation, a previously unnoticed coordinated induction oftPA mRNA was found in thecal-interstitial tissue. The existence of redundant mechanisms for plasmin production in the ovary may be the cause of the normal ovulation efficiency in single deficient mice lacking tPA or uPA. The expression of mRNAs for PA inhibitors, types 1 and 2, was low in the ovary, with minor inductions at restricted time points. In contrast, expression of protease nexin-1 (PN-1) by granulosa cells was high during the entire periovulatory period. Among subpopulations of granulosa cells, the expression of PN-1 and uPA was heterogeneous and complementary. Cumulus cells expressed high levels of PN-1 mRNA and low levels of uPA mRNA, thereby providing an inhibitory activity that may protect the mucified matrix of the cumulus oocyte complex from proteolytic degradation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940398     DOI: 10.1210/endo.137.12.8940398

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase.

Authors:  Robert Kuo-Kuang Lee; Chi-Chen Fan; Yuh-Ming Hwu; Chung-Hao Lu; Ming-Huei Lin; Ying-Jie Chen; Sheng-Hsiang Li
Journal:  Reprod Biol Endocrinol       Date:  2011-03-23       Impact factor: 5.211

Review 2.  Metalloproteases in gonad formation and ovulation.

Authors:  Yong Zhu
Journal:  Gen Comp Endocrinol       Date:  2021-10-02       Impact factor: 2.822

3.  Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation.

Authors:  Schu-Rern Chern; Sheng-Hsiang Li; Chung-Hao Lu; Edmund I Tsuen Chen
Journal:  Reprod Biol Endocrinol       Date:  2010-10-27       Impact factor: 5.211

4.  Involvement of the serine protease inhibitor, SERPINE2, and the urokinase plasminogen activator in cumulus expansion and oocyte maturation.

Authors:  Chung-Hao Lu; Robert Kuo-Kuang Lee; Yuh-Ming Hwu; Ming-Huei Lin; Ling-Yu Yeh; Ying-Jie Chen; Shau-Ping Lin; Sheng-Hsiang Li
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

5.  Periodicity in the levels of serum plasminogen activator inhibitor-1 is a robust prognostic factor for embryo implantation and clinical pregnancy in ongoing IVF cycles.

Authors:  Bindu N Mehta; Nirmalendu Nath; Natachandra Chimote
Journal:  J Hum Reprod Sci       Date:  2014-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.